Global Bacille Calmette-Guerin Vaccine Market Growth 2025-2031

The global Bacille Calmette-Guerin Vaccine market size is predicted to grow from US$ 78.7 million in 2025 to US$ 94.8 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.

The Bacille Calmette-Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). Developed from a strain of weakened Mycobacterium bovis, the BCG vaccine is commonly administered to infants and children in countries where tuberculosis is prevalent. While it does not provide complete immunity, it significantly reduces the risk of severe forms of TB, such as TB meningitis and miliary tuberculosis in young children. BCG is also being researched for potential applications in treating bladder cancer and boosting immune responses in certain conditions.

The primary drivers of the Bacille Calmette-Guérin (BCG) vaccine market is the continued high prevalence of tuberculosis (TB) in many parts of the world, particularly in Asia and Africa. Increased awareness and government initiatives to control and eradicate TB contribute to demand for the vaccine. Additionally, ongoing research on the potential use of the BCG vaccine in treating other diseases, such as bladder cancer and potentially as a non-specific immune booster, is also bolstering its market demand.

A major challenge in the BCG vaccine market is supply constraints due to the limited number of manufacturers, as production requires specialized facilities and quality control measures. Additionally, the vaccine's effectiveness varies by region and is less protective in adults than in children, which affects its perception and demand in some areas. Furthermore, stringent regulatory standards and the relatively long time required for production can limit supply, especially during times of increased demand or global health crises. Asia-Pacific is the largest consumption place, with a consumption market share nearly 46% in 2023. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 36%. Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, etc. are the leaders of the industry.

LP Information, Inc. (LPI) ' newest research report, the “Bacille Calmette-Guerin Vaccine Industry Forecast” looks at past sales and reviews total world Bacille Calmette-Guerin Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Bacille Calmette-Guerin Vaccine sales for 2025 through 2031. With Bacille Calmette-Guerin Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacille Calmette-Guerin Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Bacille Calmette-Guerin Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacille Calmette-Guerin Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacille Calmette-Guerin Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacille Calmette-Guerin Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacille Calmette-Guerin Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Bacille Calmette-Guerin Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Immune Vaccine

Therapy Vaccine

Segmentation by Application:

Self-Procurement

UNICEF

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Merck

Japan BCG Lab

Serum Institute of India

AJ Vaccines

BioFarma

GreenSignal Bio Pharma

China National Biotec

Biomed Lublin

Taj Pharmaceuticals

Ataulpho de Paiva

IVAC – Institute of Vaccines and Medical Biologicals

Queen Saovabha Mem. Inst

Microgen

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bacille Calmette-Guerin Vaccine market?

What factors are driving Bacille Calmette-Guerin Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bacille Calmette-Guerin Vaccine market opportunities vary by end market size?

How does Bacille Calmette-Guerin Vaccine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.